奇正藏药 (002287)

Tibet Cheezheng Tibetan Medicine Co.,Ltd

ASZ

K-Line Chart

No K-line data available

Company NameTibet Cheezheng Tibetan Medicine Co., Ltd.
Listing Date2009-08-28
Issue Price11.81RMB
Registered Capital53108.612810k RMB
Legal RepresentativeLiu Kailie
Registered AddressNo. 2 Deji Road, Bayi District, Nyingchi City, Tibet
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of Tibetan medicine, including external analgesic drugs and oral Tibetan patent medicines.
Company ProfileTibet Cheezheng Tibetan Medicine Co., Ltd. (referred to as Cheezheng Tibetan Medicine) is a well-known domestic Tibetan medicine manufacturer, primarily engaged in the research, development, production, and sales of new Tibetan medicines. It currently has 16 wholly-owned and holding subsidiaries, including GMP pharmaceutical factories and GSP marketing companies, and holds 72 drug approval numbers. Its products cover the fields of cardiovascular and cerebrovascular, respiratory system, digestive system, urogenital system, nervous system, musculoskeletal system, and gynecological diseases. Among them, the external analgesic drug series represented by Cheezheng Xiaotong Plaster has been best-selling for many years with a high clinical efficacy rate, ranking among the top in sales in China's external analgesic drug market.

Stock Details

1. Key Indicators

  • Total Shares(W): 57211.82
  • Circulating A-Shares(W): 57098.98
  • Earnings Per Share(RMB): 0.7912
  • Net Assets Per Share(RMB): 8.3934
  • Operating Revenue(W RMB): 152294.38
  • Total Profit(W RMB): 47224.53
  • Net Profit Attributable to Parent(W RMB): 42351.90
  • Net Profit Growth Rate(%): 7.66
  • Weighted Return on Equity(%): 9.8800
  • Operating Cash Flow Per Share(RMB): 0.8780
  • Undistributed Profit Per Share(RMB): 4.1319
  • Capital Reserve Per Share(RMB): 2.4519

2. Main Business

The main business covers:

  • Research, development, production, and sales of Tibetan medicine.

3. Company Basic Information

  • Company Name: Tibet Cheezheng Tibetan Medicine Co., Ltd.
  • Listing Date: 2009-08-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 2 Deji Road, Bayi District, Nyingchi City, Tibet Autonomous Region
  • Website: www.cheezheng.com.cn
  • Company Profile: The company was established through the overall transformation of Tibet Nyingchi Cheezheng Tibetan Medicine Factory (Co., Ltd.). Tibet Nyingchi Cheezheng Tibetan Medicine Factory was a privately-owned limited liability company registered with the Tibet Nyingchi Prefecture Administration for Industry and Commerce on December 31, 1997, as verified by the Gansu Fair Audit Firm's (1997) Gan Gong Shen Zheng Zi No. 010 "Capital Verification Report". In August 2007, Tibet Nyingchi Cheezheng Tibetan Medicine Factory legally changed its name to Tibet Nyingchi Cheezheng Tibetan Medicine Factory (Co., Ltd.). In October 2007, based on the "Audit Report" (Lianda Shen Zi [2007] No. A1552) and "Capital Verification Report" (Lianda Yan Zi [2007] No. A1078) issued by Lianda Xilong Certified Public Accountants Co., Ltd., Tibet Nyingchi Cheezheng Tibetan Medicine Factory (Co., Ltd.) was transformed into Tibet Cheezheng Tibetan Medicine Co., Ltd., and obtained the business license with registration number 5400001001123 on October 9, 2007.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Gansu Cheezheng Industrial Group Co., Ltd. General Legal Person 36454.65 63.84
2 Tibet Yutuo Culture Development Co., Ltd. General Legal Person 9839.52 17.23
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 916.85 1.61
4 China Europe Value Select Hybrid Securities Investment Fund A Class Fund 121.91 0.21
5 Tibet Cheezheng Tibetan Medicine Co., Ltd. - 2024 Employee Stock Ownership Plan (First Phase) Asset Management Plan 58.15 0.10

5. Concept Sectors

  • Infant and Child Concept
  • Innovative Drugs
  • Margin Trading and Securities Lending
  • High-Performance Stocks
  • SME 300 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information